271

AECOS 2022 Winter Symposium
American-European Congress of Ophthalmic Surgery

AECOS 2022 Winter Symposium
American-European Congress of Ophthalmic Surgery

Datum
27.02.2022 - 02.03.2022
Symposium
Colorado
Sprache
Englisch
Gebühren ab
300.00 USD
Veranstalter
American-European Congress of Ophthalmic Surgery
AECOS

Organisator

Trudy Larkins
Executive Director
Ph:  (949) 861-0987

The AECOS® welcomes to the 2022 Winter Symposium. This conference, evolved from the Dulaney-Aspen Invitational Refractive Symposium which began over 30 years ago, is the legacy AECOS meeting. Convened annually in Aspen, the AECOS Winter Symposium assembles ophthalmologists, scientists, entrepreneurs and industry experts to debate and direct innovation in anterior segment surgery. The AECOS Winter Symposium celebrates a rich history of technology debuts, including laser refractive surgery.
  • Basisinformation
    Datum
    27.02.2022 - 02.03.2022
    Symposium
    Colorado
    Sprache
    Englisch
    Gebühren ab
    300.00 USD
    Veranstalter
    American-European Congress of Ophthalmic Surgery
    AECOS

    Organisator

    Trudy Larkins
    Executive Director
    Ph:  (949) 861-0987

  • VERANSTALTUNGSORT
    St Regis HotelAspen
    315 E Dean St
    CO 81611 Colorado, US
  • Programm

    The scientific program has not been published yet.

     

  • Gebühren
    Fachärzte/-innen
    Gebühren ab
    500,00 USD
    Ärzte/-innen in Weiterbildung
    Gebühren ab
    500,00 USD
    Sonstige
    Gebühren ab
    300,00 USD
    Fee for
    -Guest of Registered Attendee
  • Buchung / Anmeldung

    Registration now open.
    Please contact the organizer for further information.

    You are the organizer?
    Would you like to link your online registration here?
    Please contact our sales team for an individual offer:
    +49 (0) 30 403 6422-0 (phone) or info@eyefox.com (e-mail).

  • Zertifizierung
    Keine Zertifizierung beantragt
  • Sponsoren
    Kala Pharmaceuticals
    Trefoil Therapeutics(Us)
    Centricity Vision
    OSRX, Inc.
    Visus Therapeutics, Inc.

Veranstaltung teilen